Key Details
Price
$16.62Last Dividend
$0.09Annual ROE
-23.67%Beta
0.57Events Calendar
Next earnings date:
May 8, 2025Recent quarterly earnings:
Jan 29, 2025Recent annual earnings:
Jan 29, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 27, 2017Next split:
N/ARecent split:
Jul 1, 2004Analyst ratings
Recent major analysts updates
Jan 30, 25 UBS
BuyJan 30, 25 Barclays
OverweightJan 23, 25 UBS
BuyJan 17, 25 Piper Sandler
OverweightDec 18, 24 Barclays
OverweightOct 23, 24 Barclays
OverweightOct 21, 24 JP Morgan
NeutralSep 3, 24 UBS
BuyAug 1, 24 Barclays
OverweightJul 11, 24 UBS
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Events
Dividend per share
Dividend yield
Other
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Teva Pharmaceutical Industries Limited?
- Does Teva Pharmaceutical Industries Limited pay dividends?
- What sector is Teva Pharmaceutical Industries Limited in?
- What industry is Teva Pharmaceutical Industries Limited in?
- What country is Teva Pharmaceutical Industries Limited based in?
- When did Teva Pharmaceutical Industries Limited go public?
- Is Teva Pharmaceutical Industries Limited in the S&P 500?
- Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?
- Is Teva Pharmaceutical Industries Limited in the Dow Jones?
- When was Teva Pharmaceutical Industries Limited's last earnings report?
- When does Teva Pharmaceutical Industries Limited report earnings?
- Should I buy Teva Pharmaceutical Industries Limited stock now?
What is the ticker symbol for Teva Pharmaceutical Industries Limited?
The ticker symbol for Teva Pharmaceutical Industries Limited is NYSE:TEVA
Does Teva Pharmaceutical Industries Limited pay dividends?
No, Teva Pharmaceutical Industries Limited does not pay dividends
What sector is Teva Pharmaceutical Industries Limited in?
Teva Pharmaceutical Industries Limited is in the Healthcare sector
What industry is Teva Pharmaceutical Industries Limited in?
Teva Pharmaceutical Industries Limited is in the Drug Manufacturers - Specialty & Generic industry
What country is Teva Pharmaceutical Industries Limited based in?
Teva Pharmaceutical Industries Limited is headquartered in Israel
When did Teva Pharmaceutical Industries Limited go public?
Teva Pharmaceutical Industries Limited's initial public offering (IPO) was on February 16, 1982
Is Teva Pharmaceutical Industries Limited in the S&P 500?
No, Teva Pharmaceutical Industries Limited is not included in the S&P 500 index
Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?
No, Teva Pharmaceutical Industries Limited is not included in the NASDAQ 100 index
Is Teva Pharmaceutical Industries Limited in the Dow Jones?
No, Teva Pharmaceutical Industries Limited is not included in the Dow Jones index
When was Teva Pharmaceutical Industries Limited's last earnings report?
Teva Pharmaceutical Industries Limited's most recent earnings report was on Jan 29, 2025
When does Teva Pharmaceutical Industries Limited report earnings?
The next expected earnings date for Teva Pharmaceutical Industries Limited is May 8, 2025
Should I buy Teva Pharmaceutical Industries Limited stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions